Literature DB >> 10325764

Acute cerebellar ataxia with human parvovirus B19 infection.

Y Shimizu1, T Ueno, H Komatsu, H Takada, T Nunoue.   

Abstract

A 2 year old boy developed acute cerebellar ataxia in association with erythema infectiosum. During the disease, genomic DNA and antibodies against human parvovirus B19 were detected in serum but not in cerebrospinal fluid. Parvovirus B19 associated acute cerebellar ataxia might occur due to transient vascular reaction in the cerebellum during infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325764      PMCID: PMC1717811          DOI: 10.1136/adc.80.1.72

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  [A case of acute cerebellar ataxia with abnormal single photon emission computed tomography].

Authors:  S Yazawa; T Ohi; S Sugimoto; S Matsukura
Journal:  Rinsho Shinkeigaku       Date:  1995-04

2.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

3.  Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection.

Authors:  H Ito; S Sayama; S Irie; N Kanazawa; T Saito; H Kowa; S Haga; K Ikeda
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

4.  A new genome type of human parvovirus B19 present in sera of patients with encephalopathy.

Authors:  K Umene; T Nunoue
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

5.  Aseptic meningitis caused by human parvovirus B19.

Authors:  A Okumura; T Ichikawa
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

6.  CT and MR imaging of acute cerebellar ataxia.

Authors:  H Shoji; S Hirai; K Ishikawa; M Aramaki; Y Sato; T Abe; K Kojima
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

  6 in total
  6 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.

Authors:  Jacqueline A Hobbs
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

3.  Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.

Authors:  J R Kerr; F Barah; M L Chiswick; G V McDonnell; J Smith; M D Chapman; J B Bingham; P Kelleher; M N Sheppard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

Review 4.  Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors:  Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

5.  Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum.

Authors:  James K Grant; Natalie C Yin; Annette M Zaytoun; Hena Waseem; Jacqueline A Hobbs
Journal:  Cerebellum       Date:  2009-07-08       Impact factor: 3.847

Review 6.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.